Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer-Reference-Cited by-同舟云学术

Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer

Published:2020-08-13 Issue:12 Volume:59 Page:1416-1423
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Hermunen Kethe¹,Soveri Leena-Maija²³,Boisen Mogens Karsbøl⁴,Mustonen Harri K.¹⁵,Dehlendorff Christian⁶,Haglund Caj H.¹⁵,Johansen Julia Sidenius⁴⁷⁸,Osterlund Pia²⁹^ORCID

Affiliation:

1. Department of Gastrointestinal Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

2. Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

3. Hyvinkää Hospital and Hyvinkää Homecare, Hyvinkää, Finland

4. Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark

5. Research Programs Unit, Translational Cancer Medicine Program, University of Helsinki, Helsinki, Finland

6. Statistics and Pharmacoepidemiology, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark

7. Department of Medicine, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark

8. Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

9. Department of Oncology, Tampere University Hospital and University of Tampere, Tampere, Finland

Funder

Cancer Foundation Finland

Finska Läkaresällskapet

The Stockmann Foundation

The Waldemar von Frenckell Foundation

The Dorothea Olivia, Karl Walter and Jarl Walter Perklén Foundation

The Competitive State Research Financing of the Expert Responsibility Area of Tampere

Helsinki University Hospitals

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2020.1800086

Reference47 articles.

1. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy

3. Benson AB, Venook A, Al-Hawary MM, et al. NCCN guidelines for rectal cancer. NCCN Guidelines. 2020 Version 4. 2020 [cited 2020 Jun 3].

4. Benson AB, Venook A, Al-Hawary MM, et al. NCCN guidelines for colon cancer. NCCN Guidelines. 2020 Version 3. 2020 [cited 2020 Jun 3].

5. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Significance of Preoperative and Postoperative Evaluation of Combined Tumor Markers for Patients With Colon Cancer;Surgical Laparoscopy, Endoscopy & Percutaneous Techniques;2024-05-13

2. Prognostic value of creatine kinase (CK)-MB to total-CK ratio in colorectal cancer patients after curative resection;BMC Cancer;2024-04-29

3. Post-operative C-reactive protein as a strong independent predictor of long-term colorectal cancer outcomes: consistent findings from two large patient cohorts;ESMO Open;2024-04

4. Review—Different Electrochemical Method Employed for Biomarkers Detection in Colorectal Cancer;Journal of The Electrochemical Society;2024-03-20

5. Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer;Clinical and Translational Oncology;2024-03-07